Epratuzumab (LymphoCide)
Revision as of 18:26, 20 May 2018 by Warner-admin (talk | contribs) (Text replacement - "http://onlinelibrary.wiley.com" to "https://onlinelibrary.wiley.com")
Mechanism of action
Anti-CD22 antibody
Preliminary data
Acute lymphocytic leukemia
- Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May;165(4):504-9. Epub 2014 Mar 3. PubMed link to original article